Correlation Between Tonix Pharmaceuticals and NextCure

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tonix Pharmaceuticals and NextCure at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tonix Pharmaceuticals and NextCure into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tonix Pharmaceuticals Holding and NextCure, you can compare the effects of market volatilities on Tonix Pharmaceuticals and NextCure and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tonix Pharmaceuticals with a short position of NextCure. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tonix Pharmaceuticals and NextCure.

Diversification Opportunities for Tonix Pharmaceuticals and NextCure

0.54
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Tonix and NextCure is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Tonix Pharmaceuticals Holding and NextCure in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NextCure and Tonix Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tonix Pharmaceuticals Holding are associated (or correlated) with NextCure. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NextCure has no effect on the direction of Tonix Pharmaceuticals i.e., Tonix Pharmaceuticals and NextCure go up and down completely randomly.

Pair Corralation between Tonix Pharmaceuticals and NextCure

Given the investment horizon of 90 days Tonix Pharmaceuticals Holding is expected to generate 1.72 times more return on investment than NextCure. However, Tonix Pharmaceuticals is 1.72 times more volatile than NextCure. It trades about 0.1 of its potential returns per unit of risk. NextCure is currently generating about -0.17 per unit of risk. If you would invest  17.00  in Tonix Pharmaceuticals Holding on August 30, 2024 and sell it today you would earn a total of  2.00  from holding Tonix Pharmaceuticals Holding or generate 11.76% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Tonix Pharmaceuticals Holding  vs.  NextCure

 Performance 
       Timeline  
Tonix Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tonix Pharmaceuticals Holding has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Tonix Pharmaceuticals is not utilizing all of its potentials. The recent stock price agitation, may contribute to short-term losses for the retail investors.
NextCure 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days NextCure has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Tonix Pharmaceuticals and NextCure Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tonix Pharmaceuticals and NextCure

The main advantage of trading using opposite Tonix Pharmaceuticals and NextCure positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tonix Pharmaceuticals position performs unexpectedly, NextCure can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NextCure will offset losses from the drop in NextCure's long position.
The idea behind Tonix Pharmaceuticals Holding and NextCure pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Fundamental Analysis
View fundamental data based on most recent published financial statements
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets